LC
MURA

Lindbrook Capital’s Mural Oncology MURA Stock Holding History

Lindbrook Capital’s Portfolio MURA Stock Details MURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$1 Hold
1
– – ﹤0.01% 2779
2024
Q4 		$3 Hold
1
– – ﹤0.01% 2770
2024
Q3 		$3 Hold
1
– – ﹤0.01% 2821
2024
Q2 		$3 Hold
1
– – ﹤0.01% 2756
2024
Q1 		$5 Sell
1
-19
-95% -$92 ﹤0.01% 2644
2023
Q4 		$118 Buy
+20
New +$80 ﹤0.01% 2654

Other funds holding MURA

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Lindbrook Capital's MURA Position: Q1 2025 in Review

Lindbrook Capital held its Mural Oncology (MURA) position steady in Q1 2025 at 1 share worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #2779.

Lindbrook Capital first reported a position in MURA in Q4 2023 and has held it in 6 quarters since. The position peaked at $118 in Q4 2023. 68 funds tracked by Wall St. Rank hold MURA as of Q1 2025.

  • Lindbrook Capital held 1 share of Mural Oncology worth $1 as of Q1 2025.
  • Lindbrook Capital left its Mural Oncology share count unchanged in Q1 2025.
  • Mural Oncology made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #2779 holding.
  • Lindbrook Capital first reported a position in Mural Oncology in Q4 2023 and has held it in 6 quarters since.
  • Lindbrook Capital's Mural Oncology position peaked at $118 in Q4 2023.
  • 68 funds tracked by Wall St. Rank held Mural Oncology as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.